RxDoctor Payments DataLook up a doctor →

Matthew Benson

Pediatric Endocrinology · Orlando, FLNPI 1942358411

Payments from drug & device makers

$428,176in general payments, 2019–2025

Across 2,991 payments — averaging $143.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$378K
  • Sanofi US Services Inc.$16K
  • Sanofi$10K
  • Sanofi-aventis U.S. LLC$9K
  • Tolmar Pharmaceuticals, Inc.$6K
  • Arbor Pharmaceuticals, Inc.$4K
  • plus $6K from 16 others
$74,045in research payments, 2019–2025

Across 17 payments — averaging $4355.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$74K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$428,176 in reported general payments places this provider in the 90th percentile of 102 pediatric endocrinology providers in Florida.

See all pediatric endocrinology providers in Florida

Other pediatric endocrinology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →